NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1075 coverCirculating Nucleic Acids in Plasma and Serum IV Volume 1075 published September 2006
Ann. N.Y. Acad. Sci. 1075: 81–87 (2006). doi: 10.1196/annals.1368.010
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by LI, Y.
Articles by HAHN, S.
Search for Related Content
PubMed
PubMed Citation
Articles by LI, Y.
Articles by HAHN, S.

Cell-Free DNA in Maternal Plasma

Is It All a Question of Size?

YING LIa, WOLFGANG HOLZGREVEa, EDOARDO DI NAROb, ANGELOANTONIO VITUCCIc AND SINUHE HAHNa

a University Women's Hospital/Department of Research, Basel, Switzerland b Department of Obstetrics and Gynecology, University of Bari, Bari, Italy c Division of Haematology II, University of Bari, Bari, Italy

Key Words: circulatory DNA • prenatal diagnosis • electrophoresis • size fractionation

Address for correspondence: Sinuhe Hahn, Laboratory for Prenatal Medicine, Department of Research, University Women's Hospital, Spitalstrasse 21, CH 4031 Basel, Switzerland. Voice: +41-61-265-9224; fax: +41-61-265-9399.  e-mail: shahn{at}uhbs.ch

Fetal cell-free DNA (cf-DNA) represents only a small fraction of the total cf-DNA in maternal plasma. This feature has rendered it difficult to reliably distinguish fetal alleles which are not very disparate from maternal ones, such as those involving point mutations, by conventional polymerase chain reaction (PCR)-based approaches. It has recently been shown that cell-free fetal DNA molecules have a smaller size than comparable cf-DNA molecules of maternal origin, and that this feature can be exploited for the selective enrichment of fetal DNA sequences, thereby permitting the detection of otherwise masked fetal genetic traits. By the use of this approach, we have shown that it is possible to detect fetal genetic loci for microsatellite markers, as well as point mutations involved in disorders such as achondroplasia and beta-thalassemia.






footerLeft footerRight